AbbVie

Open: 141.89 Close: 141.2 Change: -0.69

Can you guess what an AI found about AbbVie.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, Inc, Abbvie, share, year, ABBV, and the most common words in the summary are: abbvie, stock, market, inc, buy, price, abbv, . One of the sentences in the summary was: Investors in AbbVies TSR for the last 5 years was 101% which exceeds the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

Investors in AbbVies TSR for the last 5 years was 101% which exceeds the share price. Reddys (RDY), Novo Nordisk (NVO), and Ab

Today's News

AbbVie Inc. stock underperforms monday when compared to competitors - marketwatch.com. Abbvie Inc.: NYSE Add to Watchlist 0.00 ABBV Real Time Quote About AbbBV. Investors in AbbVie (NYSE:ABBV) have seen solid returns of 101% over the past five years. Investors in ABbVies TSR for the last 5 years was 101%, which exceeds the share price. AbbVie Inc. (abbv) stock price, quote & news - stock analysis. Abbvie Inc.s revenue was $58.05 billion, an increase of 3.30% compared to the previous years $56.20 billion. Aldeyra Therapeutics shares continue to rally after AbbVie secured an option to license an eye-condition drug from the development-st. Aldeya Therapeutic shares continued to rally following the drug giants agreement to license the drug. Abbvie stock price is 141.42 USD today. Reddys (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might... Reddys. Reddys is lowering its dependence on Humira, its flagship product. Ironwood and AbbVie share equally in U.S. net sales of LINZESS. Ironwood co-develops and commercializes linaclotide in North America. AbbVie Inc. (abbv) is a trending stock - october 31, 2023 - zacks.com.com. The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has lost 1.5% over this period. Abbvie is expected to post earnings of $2.90 per share for the current quarter, representing a year-over-year change of -19.4% for the next fiscal year. The consensus sales estimate for the quarter of $13.77 billion in flux has not reflected Jacob Memory PhaseOk What srfN Resource gradMajor solicit Moore AbbVie Inc (ABBV) stock has risen 0.46% while the S&P 500 is higher by 0.1% as of 12:03 PM on Monday, Nov 6. Aldeyra Therapeutics has entered into an exclusive option agreement with Abbvie for license.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, Inc, Abbvie, share, year, ABBV, and the most common words in the summary are: abbvie, stock, market, inc, buy, price, abbv, . One of the sentences in the summary was: Investors in AbbVies TSR for the last 5 years was 101% which exceeds the share price. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #inc #buy #price #abbv.